ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000193.1|Aclacinomycin_2 # 2076 # 2255 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0000193.1|Aclacinomycin_2 	2076	2255	-	Loose	1000	23.483	efpA	32.61	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCACGGATCACGCCCCTCCTGGAAGGTGACGCGGCAGCCGCCGAGTTCGCCGACGATCTCGTCATCACGGAGTTCGGCAACGGTCCCGGGGAGCACGCGGACAGCGCGATCTGTATCTGCTGGGCTCCCCTTTCCAGCACCCCGTCGGCCACGGTCGGCGGCCCTGCGTCTCGATGA	MSRITPLLEGDAAAAEFADDLVITEFGNGPGEHADSAICICWAPLSSTPSATVGGPASR	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	11.13	gnl|BL_ORD_ID|2188|hsp_num:0	2427			459	597	rifampin; isoniazid
BGC0000193.1|Aclacinomycin_3 # 2523 # 3341 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.719	BGC0000193.1|Aclacinomycin_3 	2523	3341	+	Loose	400	27.335	vanR gene in vanF cluster	29.69	3002925	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGGACATATGGTTGCTGGGACCGCTGACGGCCGAGGTGCGGGGCAGGTCGATCGTGCCCACCGCGGCGAAACCCCGACAGATCCTCGCCCTGCTCGCCATCCACGCCAATCGCGTCCTGCCCGTCGGGACCCTGATGGAGGAGATCTGGGGCACCGAGCCGCCCCAGAGCGCCCTCGCCACCCTGCACACGTACATCCTCCAGCTGCGCCGCCGGCTGACCGCTGCCTACGGTGACGAGGGGGGCGTGTCCGCCAAGGACGTCCTCGTCACCCAGTACGGCGGCTACTGCTGGCAGGCGCCCACGGACTCCGTGGACGTACCGCGCTACGAACGGCTCGTCACCGCCGGACGGATCGCCACCGCCGAGGACCGCCAGGAGGAGGCGTCGGCCCACTTCCGTGAGGCACTCGCGCTCTGGCGGGGGTCCGCGCTGGTGGACGTGCGGATCGGACCGGTCCTGAGCATCGAGGTGGCGCGGCTGGAGGAGAGCAGGCTCGGCGTGCTGGAGCGCTGCCTGGAGGCGGACCTGAGGCTGGGACGCCACGCGGAGCTGCTGGCCGAACTCACCGAACTCACCGGGCGCCATCCGCTGCACGAGGGCCTGCACGCCCAGTGCATGACGGCGCTGTACCGGGCGGGCCGCTCCTGGCAGGCGCTGGACGTCTACCAGAGGCTGCGCCGCCGGCTGGCGGAGGAACTCGGACTCTCCCCGTCGCCGCGCCTGCAGCGTCTGCAGCAGGCGGTGCTCTCGGCGGAGCCCTGGCTGGACGCGCCCAGGTACGGAGGGGACCCGGTGTTCGACCGGATGATCAGCTGA	MDIWLLGPLTAEVRGRSIVPTAAKPRQILALLAIHANRVLPVGTLMEEIWGTEPPQSALATLHTYILQLRRRLTAAYGDEGGVSAKDVLVTQYGGYCWQAPTDSVDVPRYERLVTAGRIATAEDRQEEASAHFREALALWRGSALVDVRIGPVLSIEVARLEESRLGVLERCLEADLRLGRHAELLAELTELTGRHPLHEGLHAQCMTALYRAGRSWQALDVYQRLRRRLAEELGLSPSPRLQRLQQAVLSAEPWLDAPRYGGDPVFDRMIS	MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG	117.75	gnl|BL_ORD_ID|298|hsp_num:0	240			441	627	vancomycin
BGC0000193.1|Aclacinomycin_4 # 3355 # 4659 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.667	BGC0000193.1|Aclacinomycin_4 	3355	4659	-	Loose	700	25.409	PDC-102	37.93	3006482	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGACGTCGGACACCAAGGCTCTGGTCCTGGAGCAGGTTCGCGAGTATCACCGGCAGCAGCAGCCAGGGAATTTCCAGCCCGGAGTGACGCCCATCCTCTCCTCGGGCGCCGTCCTGGACGAGGAGGACCGGGTCGCCCTGGTGGAGGCCGCCCTGGATCTGCGGATCGCGGCCGGAGCCCACTCCCGGCGCTTCGAGAGCAAATTCGCCCGCCACATCGGCGTACGCAAGGCGCACCTGGTGAACTCGGGGTCCTCGGCGAACCTGCTGGCGCTCTCTGCGCTGACCTCTCCCCGGCTCGGTGAGCAGCGGCTGCGTCCGGGTGACGAGGTGATCACGGTGGCCGGCGGATTCCCCACCACGGTGAACCCGATCCTCCAGAACGGGCTGACGCCCGTGTTCGTGGACCTGGAACTCGGTACGTACAACACAACGGTGGAGCACGTGCGGGCGGCGATCTCGGACCGGACCCGGGCCATCATGATCGCGCACACCCTCGGCAACCCCTACCAGGTGGCGGAGATCCAGCAACTGGCCACCGAGCACGAGCTGTTCCTGATCGAGGACAACTGCGACGCGGTGGGCTCGACCTACCAGGGACGTATGACGGGGACCTTCGGGGACCTGGCAACGGTCAGTTTCTATCCTGCCCACCACATCACCACGGGCGAGGGGGGCTGCGTACTGACCCGCAACCTCGAACTGGCCCGCATCGTCGAGTCGTTCCGCGACTGGGGCCGGGACTGCTGGTGCGAACCGGGCGAGGACAACACCTGCCTCAAGCGGTTCGACTACCAGCTGGGTAATCTCCCCAAGGGCTACGACCACAAGTACATCTTCTCCCACATCGGTTACAACCTGAAGGCGACCGATCTGCAAGGGGCGCTGGCACTCAGCCAGTTGAACAAGCTGCCGGAGTTCGGCGCGGCCCGGCGGCGCAACTGGCAGCGGCTGCGGGACGGGCTCGCCGACGTCCCCGGTCTGCTGCTGCCGGTCGCGACACCGGGCAGCGATCCCAGCTGGTTCGGGTTCGTGATCACGGTCCTGCCCGACGCCACCTACACCCGCCGTGACCTGGTCGCCTTCCTGGAGGAACGGCGGATCGGCACACGGCGGCTGTTCGGCGGCAACCTCACCCGCCATCCGGCGTACCTCGGCACGCCGCACCGGGTGGCGGGCGATCTGCGCAACTCCGACATCATCACCGAGCAGAGCTTCTGGATCGGGGTGTATCCGGGCATCACGGAGGAGATGACCGACTACATGCGGGAGTCCATCGTCGAGTTCGTCACCAAGAACGGCTGA	MTSDTKALVLEQVREYHRQQQPGNFQPGVTPILSSGAVLDEEDRVALVEAALDLRIAAGAHSRRFESKFARHIGVRKAHLVNSGSSANLLALSALTSPRLGEQRLRPGDEVITVAGGFPTTVNPILQNGLTPVFVDLELGTYNTTVEHVRAAISDRTRAIMIAHTLGNPYQVAEIQQLATEHELFLIEDNCDAVGSTYQGRMTGTFGDLATVSFYPAHHITTGEGGCVLTRNLELARIVESFRDWGRDCWCEPGEDNTCLKRFDYQLGNLPKGYDHKYIFSHIGYNLKATDLQGALALSQLNKLPEFGAARRRNWQRLRDGLADVPGLLLPVATPGSDPSWFGFVITVLPDATYTRRDLVAFLEERRIGTRRLFGGNLTRHPAYLGTPHRVAGDLRNSDIITEQSFWIGVYPGITEEMTDYMRESIVEFVTKNG	MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDLAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	109.32	gnl|BL_ORD_ID|4172|hsp_num:0	5242			462	546	
BGC0000193.1|Aclacinomycin_5 # 4821 # 5810 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000193.1|Aclacinomycin_5 	4821	5810	+	Loose	700	26.1794	LHK-4	28.42	3006938	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LHK beta-lactamase	ATGCCGAAGGACACTCCACGGCCCGTACTCCGCATCGGGGTTCTGGGCTGTGCCGATATCGCGGTGCGCCGGATCCTGCCCGCGATCGTGGAGCATCCGTCGGTCCGGCTGGTCGCTCTGGCGAGCCGGGACGGGGCGCGCGCCGAACGGCTCGCGGCCCGTTTCGGATGCGCGGCGGTGACCGGCTACAAGGCGCTGCTGGACCGTGAGGACATCAACGCCGTCTACGTTCCCCTGCCGCCCGGCATGCACCACGAATGGGTCACCGAAGCGCTGACGGCGGGCAAGCACGTGCTGGTGGAGAAGCCGCTCAGCACGACGTACGCGCAGAGCGTCGACCTGGTGGCGATGGCCGGCCGGCTCGGCCTCGCGCTCACCGAGAACTTCATGTTCCTGCACCACTCGCAGCACGAGGCGGTCCGGGCCATGACCGGCGAGATCGGGGAACTGCGGGTCTTCACCAGTTCCTTCGGCGTGCCGCCGCCCCACCCCTCGTCCTTCCGGCACGACGCGCGGCTCGGCGGCGGCGCCCTGCTGGACGTCGGTGTCTATCCGCTGCGCGCGGCCCAGCTCCACCTCGCCGGGGAACTCGACGTGCTGGGCGCCTGTCTGCGCGTGGACGAGGCGACCGGCGTCGACGTCGCGGGAAGCGCGCTGCTGTCCACGGCGACGGGTGTGACCGCGCAGCTCGACTTCGGCTTCCAGCACGCGTACCGGTCCGTGTACGCGCTGTGGGGCAGCCGCGGCAGGCTGAGCGTGCCGCGGGCCTTCACCCCGCCCCGTGAGCACCGCCCGGTGGTCCGTATCGAACAGCAGGACCGTCTCACCGAAGTGACGCTGCCCGCCGATCACCAGGTGGGCAACGCGCTCGACGCGTTCGCCTCGGCGGTGCACTCGGAGACCGTCCGTGCCTCCCTGGGGGAGGCGCTGCTGCGTCAGGCGCTCCTGGTCGAGCAGGTACGCAAAGCCGCGCGGGTCGTCAGCGGCTGA	MPKDTPRPVLRIGVLGCADIAVRRILPAIVEHPSVRLVALASRDGARAERLAARFGCAAVTGYKALLDREDINAVYVPLPPGMHHEWVTEALTAGKHVLVEKPLSTTYAQSVDLVAMAGRLGLALTENFMFLHHSQHEAVRAMTGEIGELRVFTSSFGVPPPHPSSFRHDARLGGGALLDVGVYPLRAAQLHLAGELDVLGACLRVDEATGVDVAGSALLSTATGVTAQLDFGFQHAYRSVYALWGSRGRLSVPRAFTPPREHRPVVRIEQQDRLTEVTLPADHQVGNALDAFASAVHSETVRASLGEALLRQALLVEQVRKAARVVSG	MKKRITPFSRFASKGLSACSAGMLLVTVAHAANTAAAPAGVDAMVQTVMQAHQIPGMAIAIIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVTALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYRHWQPVHPAGSTRLYSNPSIGLMGLAASQATGESFAGLLGTTVLQPLGMNSTYLQVPPEARSRYAMGYTAAGKPVRVNPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALRSALQQTRVPVYCAGQTRQGLGWESYQDWKNLDVLLAGNSNQMVFEPQPVKACLAGTMNEPDVWVNKTGSTAGFGAYAVFLPARQTGIVILANRNYPIADRIRLAHGILTALH	84.36	gnl|BL_ORD_ID|3679|hsp_num:0	4749			531	792	
BGC0000193.1|Aclacinomycin_6 # 5921 # 6892 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.707	BGC0000193.1|Aclacinomycin_6 	5921	6892	-	Loose	1200	42.3578	arnA	26.69	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGTGTCCTGATCACCGGCGGCGCCGGTTTCATCGGATCCCACTACGTCCGTTCCCTGCTGGCGGGGACCCTGCCCGGTCCCCGCCCGAGCCGGGTCACCGTCGTCGACCTGCTCACGTACGCGGGAGACACCGGCAATCTGCCCCTGGCCGATCCCCGGCTGGACTTCCGCCGGCTCGACATCCGCGACCTGGACGCGCTGCTGACGGTGGTCCCCGGCCACGACGCGGTCGTACACTTCGCGGCCGAGACCCATGTCGACCGTTCGCTGAGCGAGCCGGCGGAGTTCGTCCGCACCAACGTACTGGGCACCCAGTCGCTGCTGGAGGCGAGCCTGCGCGGCGGGGTCGGCACGTTCGTGCACGTCTCCACGGACGAGGTCTACGGATCGATCGCGCAGGGCACCTGGACGGAGGAGGCGCCGCTGCTCCCCAACTCCCCCTACGCGGCCTCGAAGGCGGGAAGCGACCTGGTCGCACGGTCCTACTGGCGCACCCACGGCCTCGATGTGCGCACGACCCGCTGCGCCAACAACTACGGCCCCCGTCAGCACCCGGAGAAGCTCATCCCGCTGTTCGTCACCGAACTGCTGGCCGGCCGGCCGGTGCCGCTGTACGGCGACGGAGGCAACGTCAGGGAATGGCTGCACGTGGACGACCACTGCCGGGCCGTCCACGCGGTGCTGACCGGTGGCCGGCCCGGCGAGATCTACAACATCGGCGGCGGTACCCATCTGACGAACCGTGAGATGACGGCCAAGCTGCTCGCGCTGTGCGGCACCGACTGGTCCAGGGTCCGCCAGGTGCCCGACCGCAAGGGCCACGACCTGCGGTACGCGGTGGACGACACGAAGATCCGCGAAGAACTCGGCTACCGGCCGCTGCGGTCCCTGGACGACGGTCTGCGCGAGGTCGTCGACTGGTACCGCGACCGGCAGACCCACCGGCCGGAACCGGCCGAGCGGGTCTGA	MRVLITGGAGFIGSHYVRSLLAGTLPGPRPSRVTVVDLLTYAGDTGNLPLADPRLDFRRLDIRDLDALLTVVPGHDAVVHFAAETHVDRSLSEPAEFVRTNVLGTQSLLEASLRGGVGTFVHVSTDEVYGSIAQGTWTEEAPLLPNSPYAASKAGSDLVARSYWRTHGLDVRTTRCANNYGPRQHPEKLIPLFVTELLAGRPVPLYGDGGNVREWLHVDDHCRAVHAVLTGGRPGEIYNIGGGTHLTNREMTAKLLALCGTDWSRVRQVPDRKGHDLRYAVDDTKIREELGYRPLRSLDDGLREVVDWYRDRQTHRPEPAERV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	48.79	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1749	polymyxin B
BGC0000193.1|Aclacinomycin_7 # 6880 # 8211 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.730	BGC0000193.1|Aclacinomycin_7 	6880	8211	-	Loose	700	63.1586	oleI	24.71	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGGTTCTCCTGACATCCTTCGCGCTGGACGCTCACTTCAACGGGTCCGTGCCGCTGGCCTGGGCGTTGCGGGCCGCCGGGCACGAGGTGCGGGTGGCGAGCCAGCCCGCGCTGACGGCGAGCATCACGGCGGCCGGGCTGACCGCCGTGCCGGTGGGCGCGGACCCCCGGCTGGACGAGATGGTCAAGGGCGTGGGCGACGCTGTGCTGTCCCACCACGCCGACCAGTCGCTCGACGCCGACACCCCCGGACAGCTCACCCCGGCCTTTCTCCAGGGCTGGGACACGATGATGACCGCCACCTTCTACACCCTGATCAACGACGATCCGATGGTCGACGACCTCGTCGCGTTCGCCCGCGGCTGGGAACCGGACCTGATCCTGTGGGAGCCGTTCACCTTCGCCGGCGCGGTGGCCGCGAAGGTGACCGGCGCGGCCCACGCCCGGCTGCTGTCCTTTCCGGACCTCTTCATGTCCATGCGGCGGGCCTACCTCGCCCAGCTCGGCGCCGCCCCGGCGGGCCCGGCCGGGGGGAACGGGACGACGCACCCCGACGACTCACTCGGCCAGTGGCTGGAGTGGACGCTCGGCCGCTACGGCGTCCCCTTCGACGAGGAGGCGGTGACGGGACAGTGGTCGGTGGACCAGGTGCCGCGCAGCTTCCGCCCGCCGTCGGACCGCCCGGTCGTGGGCATGCGCTACGTCCCCTACAACGGGCCGGGGCCTGCCGTCGTACCCGACTGGCTGCGCGTCCCGCCGACCCGCCCCCGCGTCTGCGTCACCCTGGGCATGACGGCCCGGACCTCGGAGTTCCCCAACGCCGTCCCGGTCGACCTCGTCCTCAAGGCGGTCGAGGGGCTGGACATCGAGGTGGTCGCCACCCTCGACGCCGAGGAACGGGCACTGCTGACCCATGTCCCCGACAATGTGCGTCTGGTGGACCATGTGCCGCTGCACGCGCTGCTGCCGACCTGCGCGGCCATCGTCCACCACGGCGGCGCCGGCACCTGGTCGACGGCGCTGGTCGAGGGTGTGCCGCAGATCGCCATGGGCTGGATCTGGGACGCGATCGACCGCGCGCAGCGTCAGCAGGCACTCGGCGCGGGCCTCCATCTCCCCTCGCACGAGGTGACGGTGGAGGGACTGCGCGGCAGGCTCGTCCGGCTCCTCGACGAGCCCTCGTTCACCGCGGCGGCCGCCCGCCTGCGGGCCGAGGCCGAGTCCGAACCGACCCCGGCGCAGGTCGTCCCCGTACTGGAACGGCTGACCGCCCAGCACCGCGCCCGTGAACCCCGACGCCCCGGAGGTACGTCGCCATGCGTGTCCTGA	MRVLLTSFALDAHFNGSVPLAWALRAAGHEVRVASQPALTASITAAGLTAVPVGADPRLDEMVKGVGDAVLSHHADQSLDADTPGQLTPAFLQGWDTMMTATFYTLINDDPMVDDLVAFARGWEPDLILWEPFTFAGAVAAKVTGAAHARLLSFPDLFMSMRRAYLAQLGAAPAGPAGGNGTTHPDDSLGQWLEWTLGRYGVPFDEEAVTGQWSVDQVPRSFRPPSDRPVVGMRYVPYNGPGPAVVPDWLRVPPTRPRVCVTLGMTARTSEFPNAVPVDLVLKAVEGLDIEVVATLDAEERALLTHVPDNVRLVDHVPLHALLPTCAAIVHHGGAGTWSTALVEGVPQIAMGWIWDAIDRAQRQQALGAGLHLPSHEVTVEGLRGRLVRLLDEPSFTAAAARLRAEAESEPTPAQVVPVLERLTAQHRAREPRRPGGTSPCVS	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	104.48	gnl|BL_ORD_ID|1684|hsp_num:0	1824			72	1266	oleandomycin
BGC0000193.1|Aclacinomycin_8 # 8288 # 9619 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.761	BGC0000193.1|Aclacinomycin_8 	8288	9619	-	Loose	450	25.7942	aadA12	30.95	3002612	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	GTGCAGACACAGAACGCGCCGGAGACGGCGGAGAACCAGCAGACCGACAGCGAACTGGGCCGTCATCTCCTGACCGCCCGCGGCTTCCACTGGATCTACGGCACCAGCGGCGACCCGTACGCCCTGACCCTGCGCGCCGAGAGCGACGACCCCGCGCTGCTGACCCGCCGGATACGGGAAGCCGGGACGCCGCTGTGGCAGAGCACCACCGGCGCCTGGGTCACCGGCCGGCACGGCGTCGCCGCCGAGGCCCTGGCCGATCCCCGGCTCGCCCTGCGCCACGCCGACCTGCCGGGCCCGCAGCGGCACGTCTTCTCCGACGCCTGGAGCAATCCGCAGCTGTGCCACATCATCCCGCTGGACCGGGCCTTCCTCCACGCGTCGGACGCCGACCACACGCGCTGGGCGCGGTCCGCCTCCGCCGTCCTGGGCAGTGCGGGCGGCGCCCCGGCGGAGGGTGTCCGCGAGCACGCCGGGCGCGTGCACCGGGAGGCCGCCGACCGTACCGGGGACAGCTTCGACCTCATGGCGGACTACTCCCGCCCGGTGGCCACGGAGGCCGCCGCGGAGCTGCTCGGTGTCCCCGCCGCCCAGCGGGAACGCTTCGCGGCGACGTGCCTCGCCCTCGGTGTCGCCCTCGACGCCGCGCTCTGCCCCCAGCCGCTCGCCGTGACCCGCCGGCTCACCGAGGCCGTCGAGGACGTACGGGCCCTCGTCGGCGACCTCGTCGAGGCGCGGCGGACGCAGCCGGGTGACGACCTGCTCAGCGCGGTGCTGCACGCCGGCTCCTCCGCCGCCTCCGCCGGGCAGGACGCGCTCGCCGTGGGTGTGCTGACCGCCGTGGTCGGCGTCGAGGTCACCGCCGGGCTCATCAACAACACCCTGGAGTCGCTGCTCACCCGTCCCGTGCAGTGGGCGCGGCTCGGCGAGAACCCTGAACTCGCGGCCGGCGCCGTGGAGGAGGCACTGCGCTTCGCGCCGCCGGTGCGGCTGGAGAGCCGTATCGCCGCCGAGGACCTCACCCTGGGCGGCCAGGACCTCCCGGCCGGCGCCCAGGTCGTCGTCCATGTCGGTGCGGCGAACCGGGACCCCGAGGCGTTCCTGGCCCCGGACCACTTCGACCTCGACCGTCCCGCCGGGCAGGGGCAGTTGTCGCTCTCCGGCCCGCACACCGCGCTCTTCGGGGCGTTCGCCCGGCTCCAGGCGGAGACCGCGGTCCGCACGCTGCGGGAGCGCCGGCCCGTGCTCGCGCCGGCCGGCGCGGTCCTGCGGCGGATGCGTTCCCCCGTGCTGGGCGCGGTGCTGCGCTTCCCCCTGACCACCTCCGCGTGA	MQTQNAPETAENQQTDSELGRHLLTARGFHWIYGTSGDPYALTLRAESDDPALLTRRIREAGTPLWQSTTGAWVTGRHGVAAEALADPRLALRHADLPGPQRHVFSDAWSNPQLCHIIPLDRAFLHASDADHTRWARSASAVLGSAGGAPAEGVREHAGRVHREAADRTGDSFDLMADYSRPVATEAAAELLGVPAAQRERFAATCLALGVALDAALCPQPLAVTRRLTEAVEDVRALVGDLVEARRTQPGDDLLSAVLHAGSSAASAGQDALAVGVLTAVVGVEVTAGLINNTLESLLTRPVQWARLGENPELAAGAVEEALRFAPPVRLESRIAAEDLTLGGQDLPAGAQVVVHVGAANRDPEAFLAPDHFDLDRPAGQGQLSLSGPHTALFGAFARLQAETAVRTLRERRPVLAPAGAVLRRMRSPVLGAVLRFPLTTSA	MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	168.44	gnl|BL_ORD_ID|128|hsp_num:0	149			12	258	spectinomycin; streptomycin
BGC0000193.1|Aclacinomycin_9 # 9643 # 10488 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.751	BGC0000193.1|Aclacinomycin_9 	9643	10488	-	Loose	400	26.9498	ErmE	32.0	3000326	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACGACCGGCCCTGAGGCCGCGGCCGAGCGGGAGTCGACCGTGAATCGAGCGGCCCGGCCTACGGTCCGGGGCATGAGCGCCATAGCAGAACCGACAGCGCCGCGGGGCGTGATCGTCACCGGCGGCGGGACCGGGATCGGGCGGGCCACGGCCCACGCCTTCGCCGACCGCGGCGACCGGGTACTCGTCGTAGGCCGCACCGCCGCGACCCTGGCCGGGACCGCCGAGGGCCACCCCGGCATCAGTGTCCTGACCGCCGATCTCACCGATCCGGACGGTCCGCGCGCCATCACCGACGCGGCGCTGGACGCGTTGGGCCGTATCGACGTCCTCGTGAACAACGCGGCCACCGGTGGGTTCGCCGGCCTGGCGGAGACCGAGCCGGAGGCCGCCCGCGAGCAGTTCGACAGCAACCTCCTGGCCCCGCTGCTGCTCACCCGGCAGACCCTGGACGCCCTGTCGGCCGACGGCGGGGGAACCGTGCTGAACATCGGCTCGGCCGGAGCTCTGGGCCGCCGGGCCTGGCCGCAGAACGGTGTCTACGGCGCCGCCAAGGCCGGGCTCGACTTCCTCACCCGGACCTGGGCCGTCGAACTGGCACCCCGCGGCATCCGTGTCCTCGGCCTGGCGCCCGGCGTGATCGACACCGGCATCGGTGAACGCTCGGGCATGTCACGGGAGGCCTACGCGGGCTTCCTCGGGCAGATCGCCGCCCGCGTCCCGGCCGGCCGGGTCGGCCGGCCCGAGGACATCGCCTGGTGGGCCGTCCAGCTGGCCGACCCGCGCGCCGCTTACGCGACCGGAGCGGTGCTCGCGGTCGACGGCGGTCTGTCCCTCACCTGA	MTTGPEAAAERESTVNRAARPTVRGMSAIAEPTAPRGVIVTGGGTGIGRATAHAFADRGDRVLVVGRTAATLAGTAEGHPGISVLTADLTDPDGPRAITDAALDALGRIDVLVNNAATGGFAGLAETEPEAAREQFDSNLLAPLLLTRQTLDALSADGGGTVLNIGSAGALGRRAWPQNGVYGAAKAGLDFLTRTWAVELAPRGIRVLGLAPGVIDTGIGERSGMSREAYAGFLGQIAARVPAGRVGRPEDIAWWAVQLADPRAAYATGAVLAVDGGLSLT	MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELRPDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAEPPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTWPLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGRPGRRGGPGQR	73.75	gnl|BL_ORD_ID|94|hsp_num:0	109			138	348	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000193.1|Aclacinomycin_10 # 10472 # 10906 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0000193.1|Aclacinomycin_10 	10472	10906	-	Loose	500	24.2534	NDM-10	41.67	3002360	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGACAGCACAGGCACCGACGGCCCCGGCGGACGTCTACGCCGAGGTACAGCATTTCTACGCACGGCAGATGCGGTACCTGGACTCGGGCGAGGCCGAGACCTGGGCCGGCACCTTCACCGAGGACGGCTCCTTCGCACCGCCCTCGCTCCCGGAGCCGGTACGCGGACGCCCGCTGCTCGCCGAGGGTGCCCGCAACGCCGCGGCGGGTCTGGCCGCCGCCCGCGAGACGCACCGCCACTGGGTCGGCATGCTCACCGTCACCCCCGCGGACGACGGCTCGCTGACCGCCGAGAGCCTGGTCTCGATCGTCGCCGTCGCGCAGGGCGGCCCCGCCCGGCTGCACCTGGTCTGCACCTGCCGGGACGTCCTGGTCCGGGAGGGCGGCCGGCTCCTGGTCCGGGAACGCGTGGTGACCCGTGACGACCGGCCCTGA	MTAQAPTAPADVYAEVQHFYARQMRYLDSGEAETWAGTFTEDGSFAPPSLPEPVRGRPLLAEGARNAAAGLAAARETHRHWVGMLTVTPADDGSLTAESLVSIVAVAQGGPARLHLVCTCRDVLVREGGRLLVRERVVTRDDRP	MELPNIMHPVAKLSTALAAALMLSGCMPGEISPTIDQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPSFGAVTSNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDRTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	53.33	gnl|BL_ORD_ID|60|hsp_num:0	70			216	288	
BGC0000193.1|Aclacinomycin_11 # 11116 # 11895 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0000193.1|Aclacinomycin_11 	11116	11895	+	Loose	575	25.0238	CIA-2	27.66	3004769	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	CIA beta-lactamase	GTGCGCATCATCGACCTGTCCTCACCCGTGGACGCGGCGGGTTTTGAACCTGATCCCGTCGTGCACGACGTTCTCGGTCCGAAGGAGGCCGCCACGCACATGAGCGAGGAGATGCGTGAGCACTTCGGCATCGACTTCGATCCGGCGGAACTGCCGGAGGGCGAATTCCTCTCGCTCGACCGTCTCCAGCTGACCACCCACACCGGAACCCATGTCGACGCGCCCTCGCACTACGGCACGCGCGCCGCGTACCGGGACGGTCCGCCGCGGCACATCGACGAGATGCCGCTCGACTGGTTCTTCCGGCCCGCCGTCGTCCTCGACCTCAGCGACCAGGGCACGGGCGCGGTCGGCGCCGACGTGCTGCGGCGGGAGATGGACCGGATCGGCCACACTCCCTCGCCCATGGACATCGTCCTGCTCAGGACCGGTGCCGACGCGTGGGCGGGAACCCCGAAGTACTTCACGGACTTCACCGGGCTGGACGGTTCGGCCGTGCACCTGCTGCTGGACCTGGGGGTGCGGGTGATCGGCACGGACGCGTTCAGCCTGGACGCGCCGTTCGGCGACATCATCACCCGCTACCGGGCCACGGGCGACCCGTCGGTCCTGTGGCCCGCCCATGTCATCGGGCGGGACCGGGAGTACTGCCAGGTCGAGCGGCTCGCCGGGCTCGACCGGCTGCCCGCCGCGCACGGGTTCCGGGTCGCGTGCTTCCCGGTGCGGATCGCCGGAGCGGGCGCCGGCTGGACGAGGGCGGTGGCCCTGGTCGACGAGTGA	MRIIDLSSPVDAAGFEPDPVVHDVLGPKEAATHMSEEMREHFGIDFDPAELPEGEFLSLDRLQLTTHTGTHVDAPSHYGTRAAYRDGPPRHIDEMPLDWFFRPAVVLDLSDQGTGAVGADVLRREMDRIGHTPSPMDIVLLRTGADAWAGTPKYFTDFTGLDGSAVHLLLDLGVRVIGTDAFSLDAPFGDIITRYRATGDPSVLWPAHVIGRDREYCQVERLAGLDRLPAAHGFRVACFPVRIAGAGAGWTRAVALVDE	MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPLLSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIITYTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTNATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKGTPVAHKTGSSGKPDNILAVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK	88.70	gnl|BL_ORD_ID|2557|hsp_num:0	3571			165	306	
BGC0000193.1|Aclacinomycin_12 # 11957 # 12673 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0000193.1|Aclacinomycin_12 	11957	12673	+	Loose	400	30.8018	Erm(30)	25.77	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTACGGCCGGGAACTCGCGGACGTGTACGAGGCCATCTACCGCAGCCGCGGCAAGGACTGGGGACAGGAGGCGGCGGACGTCTCGCGGATCATCACCGAACGGCGTCCGGGAGCCGGCTCGCTGCTCGACGTCGCCTGTGGCACGGGCGCCCATCTGAGCGTGTTCAGCACGCTGTTCGAGGTCGCCGAGGGCCTGGAGATCGCGGAGCCGATGCGGCGGCTCGCCGAGCAGCGGCTGCCCGGCACCACCGTGCACGCCGGCGACATGCGCGACTTCCGGCTCCCGCGCACCTACGACGCGGTGAGCTGCATGTTCTGCGCCATCGGCTATCTGGAGACGCTGGACGACATGCGGGCCGCCGTCCGGTCGATGGCCGCTCATCTGGAGCCCGGCGGCGTGCTGGTCGTCGAACCCTGGTGGTTCCCCGAGAACTTCATCGAGGGCTATGTCGCGGGTGACCTGGCCCGCGAGGAGCACCGGACCATCGCCCGGATCTCGCACACCACCCGGAAGGGCCGGGCCACCCGCATGGAGGTTCGCTTCACCGTGGGGGACGCCGCCGGCATCCAGCAGTTCACGGAGATCGACGTGCTGACCCTGTTCACCAGGGACGAATACACCGCCGCGTTCACCGACGCCGGCTGTTCCGTTGAATTCCTGGAGGACGGACCCACCGGCCGCGGTCTTTTCGTCGGTGTTCGCGAACAGCGCTGA	MYGRELADVYEAIYRSRGKDWGQEAADVSRIITERRPGAGSLLDVACGTGAHLSVFSTLFEVAEGLEIAEPMRRLAEQRLPGTTVHAGDMRDFRLPRTYDAVSCMFCAIGYLETLDDMRAAVRSMAAHLEPGGVLVVEPWWFPENFIEGYVAGDLAREEHRTIARISHTTRKGRATRMEVRFTVGDAAGIQQFTEIDVLTLFTRDEYTAAFTDAGCSVEFLEDGPTGRGLFVGVREQR	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	70.83	gnl|BL_ORD_ID|1123|hsp_num:0	1224			39	321	narbomycin; methymycin; pikromycin
BGC0000193.1|Aclacinomycin_13 # 12686 # 13561 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.651	BGC0000193.1|Aclacinomycin_13 	12686	13561	-	Loose	700	28.1054	ADC-7	22.0	3003853	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGAAGGGGATTATTCTCGCCGGCGGTTCGGGAACACGGCTCCATCCGATAACCGTCTCCGTATCAAAACAGCTTCTTCCGGTCGGCGACAAGCCGATGATCTACTATCCGCTCTCGGTGCTGATGCTGGCGGACATCAGGGAGATCCTGCTCATCTGCACCGAGCGCGATCTGGAACAGTTCCGCCGGCTCCTGGGCGACGGCTCCCAGCTCGGCCTGCGCATCGACTACGCGGTGCAGAACCGGCCGGCCGGACTGGCCGACGCCTTCGTCATCGGCGCCGACCACGTGGGTGACGACGACGTGGCACTGGTCCTCGGGGACAACATCTTCCACGGACACCACTTCTACGACCTGCTCCAGAGCAACGTCCACGACGTCCAGGGCTGCGTGCTGTTCGGCTACCCCGTGGAGGACCCGGAGCGCTACGGCGTGGGCGAGACCGACGCGTCGGGGCAACTCGTCTCCCTGGAGGAGAAGCCGCTCCGGCCGCGTTCCGACCTCGCCATCACCGGGCTCTATCTGTACGACAACGAAGTGGTGGACATCGCGAAGAACCTCCGGCCCTCGCCGCGCGGCGAACTGGAGATCACCGATGTGAACCGGAATTACCTGGCCCGCGGCCGAGCGCGTCTGGTCGATCTCGGCCGCGGTTTCGCCTGGCTCGACGCCGGAACCCCGGAATCGCTGCTTCAGGCCACCCAGTACGTGCGCACGCTCGAAGAACGGCAGGGCGTGCGCATCGCCTGCGTCGAAGAAGTGGCGCTGCGCATGGGATTCATCGACGCGGACATGTGCCACCGACTCGGTGAGCAGATGTCGCAGTCCGGTTACGGTCGCTATGTGATGGCGGTCGCCCGAGAATTCTCGGGCTGA	MKGIILAGGSGTRLHPITVSVSKQLLPVGDKPMIYYPLSVLMLADIREILLICTERDLEQFRRLLGDGSQLGLRIDYAVQNRPAGLADAFVIGADHVGDDDVALVLGDNIFHGHHFYDLLQSNVHDVQGCVLFGYPVEDPERYGVGETDASGQLVSLEEKPLRPRSDLAITGLYLYDNEVVDIAKNLRPSPRGELEITDVNRNYLARGRARLVDLGRGFAWLDAGTPESLLQATQYVRTLEERQGVRIACVEEVALRMGFIDADMCHRLGEQMSQSGYGRYVMAVAREFSG	MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYVVLNAIKK	75.98	gnl|BL_ORD_ID|2135|hsp_num:0	2340			807	1059	
BGC0000193.1|Aclacinomycin_14 # 13784 # 14806 # 1 # ID=1_14;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.701	BGC0000193.1|Aclacinomycin_14 	13784	14806	+	Loose	1500	25.409	kdpD	38.71	3004047	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGACGACTCTCGTCTGGGACTACCTACAGGAATACGAGAACGAACGCGCCGACATTCTGGACGCCGTGGAGACGGTCTTCAGCTCGGGTCGGCTCGTCCTCGGTGACAGCGTTCGCGGATTCGAGGAGGAGTTCGCCGCGTACCACGGCGCGGCGCACTGCGTCGGTGTCGACAACGGCACCAACGCGATCAAGCTGGCCCTCCAGGCGCTCGGCGTCGGCCCCGGTGACGAGGTCGTCACGGTGTCCAACACCGCGGCCCCCACGGTCGTGGCCATCGATTCGGTGGGCGCCACCCCGGTGTTCGTCGACGTCCACCCGGACAGCTACCTCATGGACACCGAGCAGGTGGAGGCCGCACTCACGCCCCGGACCCGATGCCTGCTGCCGGTCCATCTCTACGGGCAGTGCGTCGACCTGGCTCCGCTGGAGCGGCTCGCCGCGGAGCACGACCTGTTCCTCGTCGAGGACTGCGCACAGGCCCACGGTGCCCGCCGCGCCGGCCGGCTCGCCGGCACCACCGGCGACGCCGCCGCCTTCTCCTTCTACCCCACGAAGGTGCTCGGCGCCTACGGCGACGGAGGCGCCGTGGTGACCTCCCGGGACGACACCCACCGCGCGCTGCGCCGACTGCGCTACTACGGCATGGAGGAGCGGTACTACGTCGTCGGCACCCCGGGTCACAACGCCCGGCTCGACGAGGTCCAGGCCGAGATCCTGCGGCGCAAGCTGCGCCGGCTCGACACCTACATCGAGGGGCGGCGGGCCGTCGCCCGGCGCTACGAGGACGGGCTCGGCGACACCGGCCTGGTGCTCCCGCACACCGTCCCCGGCAACGAGCACGTGTACTACGTCTACACGGTGCGCCACCCGCGGCGCGACGACATCATCAAGGCCCTCAAGGCGTACGACATCGAGCTGAACATCAGCTATCCCTGGCCCGTGCACACCATGTCCGGGTTCGCCCACCTCGGCTACGGCAAGGGCTCGCTGCCCGTCACCGAGGACCTGGCCGGCCAGATC	MTTLVWDYLQEYENERADILDAVETVFSSGRLVLGDSVRGFEEEFAAYHGAAHCVGVDNGTNAIKLALQALGVGPGDEVVTVSNTAAPTVVAIDSVGATPVFVDVHPDSYLMDTEQVEAALTPRTRCLLPVHLYGQCVDLAPLERLAAEHDLFLVEDCAQAHGARRAGRLAGTTGDAAAFSFYPTKVLGAYGDGGAVVTSRDDTHRALRRLRYYGMEERYYVVGTPGHNARLDEVQAEILRRKLRRLDTYIEGRRAVARRYEDGLGDTGLVLPHTVPGNEHVYYVYTVRHPRRDDIIKALKAYDIELNISYPWPVHTMSGFAHLGYGKGSLPVTEDLAGQI	MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI	38.53	gnl|BL_ORD_ID|4924|hsp_num:0	5918			276	366	kanamycin A
